ASHLEY TAYLOR: Open Payments
NPI 1063054955 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,504 in 21 payments from 11 companies in 2025. Trend: 2023 $1,080 · 2024 $588 · 2025 $1,504
Food & beverage: $1,504
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $289 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $241 |
| Vanda Pharmaceuticals Inc. | 2 | $215 |
| ABBVIE INC. | 1 | $124 |
| Eisai Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| E.R. Squibb & Sons, L.L.C. | 2 | $116 |
| Neurelis, Inc. | 1 | $115 |
| Alexion Pharmaceuticals, Inc. | 1 | $104 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
Products named: REXULTI, CAPLYTA, FANAPT, UBRELVY, Leqembi, Auvelity, COBENFY, VALTOCO.
Industry payments across AR — which companies pay providers there.
